Akoya Biosciences Inc (AKYA)
2.14
+0.02
(+0.94%)
USD |
NASDAQ |
Nov 22, 12:22
Akoya Biosciences Gross Profit Margin (Quarterly): 62.32% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 62.32% |
| June 30, 2024 | 57.79% |
| March 31, 2024 | 45.66% |
| December 31, 2023 | 62.75% |
| September 30, 2023 | 60.58% |
| June 30, 2023 | 51.51% |
| March 31, 2023 | 57.42% |
| December 31, 2022 | 56.77% |
| September 30, 2022 | 57.86% |
| June 30, 2022 | 57.79% |
| Date | Value |
|---|---|
| March 31, 2022 | 59.76% |
| December 31, 2021 | 63.29% |
| September 30, 2021 | 62.73% |
| June 30, 2021 | 62.23% |
| March 31, 2021 | 60.64% |
| December 31, 2020 | 61.26% |
| September 30, 2020 | 60.62% |
| June 30, 2020 | 61.57% |
| March 31, 2020 | 60.76% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
45.66%
Minimum
Mar 2024
63.29%
Maximum
Dec 2021
59.12%
Average
60.62%
Median
Sep 2020
Gross Profit Margin (Quarterly) Benchmarks
| Bruker Corp | 48.45% |
| Azenta Inc | 40.82% |
| Harvard Bioscience Inc | 58.10% |
| Bionano Genomics Inc | -139.1% |
| Singular Genomics Systems Inc | -74.14% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -157.2% |
| Return on Assets | -36.87% |
| Return on Invested Capital | -52.65% |
| Profit Margin (Quarterly) | -55.98% |
| Operating Margin (Quarterly) | -39.45% |
| Return on Net Operating Assets | -64.85% |